Parkinson's Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with Parkinson's disease
- People whose brain scans (a specific type of PET scan) have confirmed a buildup of a protein called amyloid in the brain
- People who have mild memory or thinking difficulties, based on neuropsychological testing (scored at CDR 0.5 or 1, which indicates mild cognitive impairment or early dementia)
- Adults between the ages of 50 and 90 years
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People for whom the study drug, lecanemab, would be considered unsafe or unsuitable based on guidelines from the Korean Dementia Association
- People whose brain condition is suspected to be caused by something other than Parkinson's disease or Alzheimer's disease
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 82-2-2228-1608
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Changes in amyloid dposition on amyloid imaging scans
Can't join this trial?
Data last synced from ClinicalTrials.gov: 18 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.